Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of aTyr Pharma (ATYR) with Overweight RecommendationFintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...
Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...
Equities research analysts at Cantor Fitzgerald started coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com ...
After hours: January 3 at 7:33:23 p.m. EST ...
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...
NervGen Pharma (TSE:NGEN) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...
Moreover, the centre’s production-linked incentive (PLI) scheme for the pharma industry has benefited the sector significantly. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance ...
The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use one or multiple different selling models. However, how many pharma executives ...
Shares of Neumora Therapeutics fell more than 80% after its depression drug failed in a key trial. The drug failed to reduce symptoms like sadness and pessimistic thoughts in people diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback